Regeneron Pharmaceuticals Stock Forecast - Jensen Alpha
| REGN Stock | USD 754.87 1.84 0.24% |
Regeneron Stock Forecast is based on your current time horizon. Although Regeneron Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Regeneron Pharmaceuticals' systematic risk associated with finding meaningful patterns of Regeneron Pharmaceuticals fundamentals over time.
Regeneron |
| Check Regeneron Pharmaceuticals Volatility | Backtest Regeneron Pharmaceuticals | Information Ratio |
Regeneron Pharmaceuticals Trading Date Momentum
| On November 28 2024 Regeneron Pharmaceuticals was traded for 754.87 at the closing time. The top price for the day was 762.15 and the lowest listed price was 749.52 . There was no trading activity during the period 0.0. Lack of trading volume on November 28, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.25% . |
| Compare Regeneron Pharmaceuticals to competition |
Other Forecasting Options for Regeneron Pharmaceuticals
For every potential investor in Regeneron, whether a beginner or expert, Regeneron Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Regeneron Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Regeneron. Basic forecasting techniques help filter out the noise by identifying Regeneron Pharmaceuticals' price trends.Regeneron Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regeneron Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Regeneron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Regeneron Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Regeneron Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Regeneron Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Regeneron Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Regeneron Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Regeneron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regeneron Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Regeneron Pharmaceuticals stock market strength indicators, traders can identify Regeneron Pharmaceuticals entry and exit signals to maximize returns.
Regeneron Pharmaceuticals Risk Indicators
The analysis of Regeneron Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Regeneron Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting regeneron stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.17 | |||
| Standard Deviation | 1.7 | |||
| Variance | 2.89 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Regeneron Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Regeneron Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Regeneron Stock
| 0.85 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.89 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.96 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Regeneron Stock
| 0.94 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.82 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.6 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.59 | PHVS | Pharvaris BV | PairCorr |
| 0.44 | ESLAW | Estrella Immunopharma | PairCorr |
The ability to find closely correlated positions to Regeneron Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Regeneron Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Regeneron Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Regeneron Pharmaceuticals to buy it.
The correlation of Regeneron Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regeneron Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regeneron Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Regeneron Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Regeneron Pharmaceuticals to cross-verify your projections. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.298 | Earnings Share 40.46 | Revenue Per Share 128.691 | Quarterly Revenue Growth 0.106 | Return On Assets 0.0741 |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.